top of page
2011 CONGRESS
National Pharmaceutical Congress V
March 30, 2011 - Toscana Conference Centre
11 Strategies for a Faster, Smarter Pharma
Moderator Introduction
David Renwick
Director, Pangaea Group
Key Issues That Keep Rx&D Members Awake
Russell Williams
President, Rx&D
Key Issues That Keep BIOTECanada Members Awake
Peter Brenders
President & CEO, BIOTECanada
Key Issues That Keep The Canadian Generic Pharmaceutical Association Members Awake
Morris Goodman
Chairman of the Board, Pharmascience Inc.
Key Issues That Keep Consumer Health Product Leaders Awake
David Skinner
President, Consumer Health Products Canada
Audience Interaction
Oxford Debate I
Moderator: Dr. Shafiq Qaadri, MPP
For the affirmative: Mark McElwain, kbs+p
For the negative: Jill Donahue, Excellerate
Resolved: This house supports the establishment of the "National Center for Advancing Translational Sciences", funded by the US Government, to speed the development of new drugs by conducting early-stage research that the pharmaceutical industry is unable or unwilling to perform
Audience Interaction
Moderator Introduction
Michael Brogan
IMS Brogran
It's Not an Option: Customer Centricity is the Future
Brian Jahns
Director of Hematology Business Unit, Hoffmann-La Roche Limited
Lifecycle Management & Forecasting
Andreas Seiger
Marketing Director Diabetes Care, Novo Nordisk Canada Inc.
The Challenge of Reimbursement
Doug Grant
Head, Corporate Affairs, Bayer Healthcare
The Tantalus Paradigm
Kevin Leshuk
General Manager, Celgene Inc.
Audience Q&A
Oxford Debate II
Moderator: Dr. Shafiq Qaadri, MPP
For the affirmative: Eileen McMahon, Torys
For the negative: Marc Lalande, Learning Andrago Inc.
Resolved: This house believes corporate intellectual property rights and worldwide human health initiatives must always be mutually exclusive concepts
Audience Interaction
Moderator Introduction
Mitch Shannon
Chronicle Companies
Selling Science: Marketing Specialty Care Products
Pat Forsythe
Neurosciences Business Unit Director, Allergan Inc.
Five Tips for a Better, Smarter Pharma
Robin Hunter
Vice-President, Critical Care, Leo Pharma Inc.
11 Strategies to Become a Faster/Smarter Pharma: The Valeant Experience
Thomas Schlader
General Manager, Valeant Canada Ltd.
The Key Learnings of the Adderall XR Suspension and
Re-Instatement of NOC in 2005
Claude Perron
Vice-President & General Manager, Shire Canada Inc.
Improving Patient Lives Program
Michael Tremblay
President, Astellas Pharma Canada Inc.
Audience Interaction
Concluding Remarks and Conference Summary
Mitch Shannon
Chronicle Companies
Canadian Healthcare Marketing Hall of Fame Reception
followed by
Canadian Healthcare Marketing Hall of Fame Gala Luncheon
bottom of page